[1]
N. Babayeva, “Cardiopulmonary Effects of Combined β1-Selective Blockers, Ivabradine, and β2-Agonists in the Ischemic Heart Disease with Chronic Obstructive Pulmonary Disease”, JHDT, vol. 3, no. 01, pp. 48–50, Jul. 2026.